‘Caution folks’: Top WHO scientist flags ‘dangerous trend’ of mixing Covid-19 vaccines

Geneva, July 12 (ANI): Mixing and matching COVID-19 vaccines from different manufacturers is a “dangerous trend” and could lead to chaos as there is limited data on it on the practice, World Health Organisation (WHO) chief scientist Soumya Swaminathan said on Monday.

Addressing a Covid-19 media briefing, Swaminathan said, “Really want to caution folks, because there is a tendency now for people in countries which enough availability of vaccines to voluntarily start thinking.”

“So it’s a little bit of a dangerous trend here where we’re in a data-free evidence-free zone as far as a mix and match there is limited data on mix and match. There are studies going on, we need to wait for that,” she added.

On the question of booster shots, WHO chief scientist said it will be a chaotic situation in countries if citizens start deciding when they should be taking a second, or a third, or a fourth dose.

“We have four countries that have announced a booster program, and a few more that are thinking about it. If 11 high and upper-middle-income countries decide to some of them are large countries that they will go for a booster for their populations or even subgroups. This will require an additional 800 million doses of vaccine.”

Stressing on the need to prioritise vaccines, Swaminathan said there are still countries where the frontline and health care workers have not been vaccinated and the elderly and the vulnerable.”

The world has so far witnessed over 186 million cases and four million deaths due to the virus, according to the Johns Hopkins University‘s data. (ANI)

  • Related Posts

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

    NHS backs delayed‑release treatment for cystinosis

    Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

    Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

    Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

    Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry